+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nimodipine"

From
Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Aneurysmal Subarachnoid Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Subarachnoid Hemorrhage - Pipeline Insight, 2024 - Product Thumbnail Image

Subarachnoid Hemorrhage - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • November 2023
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 109 Pages
  • China
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Nimodipine is a calcium channel blocker used to treat high blood pressure and other cardiovascular conditions. It is used to reduce the risk of stroke in patients with a history of transient ischemic attack (TIA) or ischemic stroke. Nimodipine is also used to reduce the risk of complications from subarachnoid hemorrhage, a type of stroke caused by bleeding in the brain. Nimodipine is available in oral and intravenous formulations. Nimodipine is a widely used drug in the cardiovascular market. It is used to treat hypertension, angina, and other cardiovascular conditions. It is also used to reduce the risk of stroke in patients with a history of TIA or ischemic stroke. Nimodipine is generally well tolerated and has few side effects. In the Nimodipine market, there are several companies that manufacture and distribute the drug. These include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Show Less Read more